OpenVSafe by OpenVAERS
Search V-safe

QY5-16181-15321

2 vaccinations 2 coded responses 15 check-ins 2 free-text entries 1 call case
Sex
Male
Age at first dose
05-11
ZIP prefix
542 / WI
Registered
2021-12-04
Relationship
Child or adolescent in my care
Guardian
BFP-20453-73462
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-12-04
    Registered in v-safe
  3. 2021-12-04
    Health check-in — day 14, dose 1, dependent
    Feeling: Good
    Adult check-in
  4. 2021-12-08
    Dose 2 — Pfizer-BioNTech
  5. 2021-12-08
    Health check-in — day 0, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-12-10
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-12-11
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-12-12
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-12-14
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  10. 2021-12-15
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2021-12-22
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2021-12-29
    Health check-in — day 21, dose 2, dependent
    Feeling: Good
    Adult check-in
  13. 2022-01-05
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2022-01-12
    Survey response — day 35, dose 2, dependent
    MedDRA: Abdominal discomfort, Dizziness, Headache, Upper-airway cough syndrome, Vision blurred — Feeling: Poor · Be unable to work or attend school
    Free text: Headache, dizzy, blurred vision, upset stomach, post nasal drip
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-01-19
    Health check-in — day 42, dose 2, dependent
    Feeling: Good
    Adult check-in
  16. 2022-03-09
    Survey response — 3 months, dose 2, dependent
    MedDRA: COVID-19, Malaise, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Covid positive and sick on Feb 2nd 2022. He's now better since testing positive and being sick just over a month ago.
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-03-09
    Report sent to call center — 3 months, dose 2, dependent
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  18. 2022-03-16
    Call successful
    Does not wish to fill out VAERS report
  19. 2022-06-08
  20. 2022-12-11

Vaccinations

DoseDateManufacturerCo-administered
12021-11-17Pfizer-BioNTech No
22021-12-08Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 10 — day 35, dose 2, dependent

2022-01-12

Symptoms: Headache, dizzy, blurred vision, upset stomach, post nasal drip

Release 11 — 3 months, dose 2, dependent

2022-03-09

Symptoms: Covid positive and sick on Feb 2nd 2022. He's now better since testing positive and being sick just over a month ago.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal discomfort · · ✓
SDCOVID-19 · · ✓
SDDizziness · · ✓
SDHeadache · · ✓
SDMalaise · · ✓
SDSARS-CoV-2 test positive · · ✓
SDUpper-airway cough syndrome · · ✓
SDVision blurred · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release